Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 5Breast Neoplasms 5Uterine Cervical Neoplasms 2Cholangiocarcinoma 2Carcinoma, Intraductal, Noninfiltrating 2Sarcoma 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Lymphedema 1Lymphatic Metastasis 1Lung Neoplasms 1Glioblastoma 1Gallbladder Neoplasms 1Endometrial Neoplasms 1Encopresis 1Carcinoma, Non-Small-Cell Lung 1Breast Carcinoma In Situ 1Breast Cancer Female 1

Interventions

Temozolomide 41Radiotherapy 19Radiation 12Nivolumab 10pembrolizumab 8Magnetic Resonance Spectroscopy 8Bevacizumab 7Specimen Handling 6poly ICLC 4atezolizumab 4Lomustine 4Ipilimumab 4Surgical Procedures, Operative 3Photons 3Immunoglobulin G 3Disulfides 3Cyclophosphamide 3veliparib 2sargramostim 2rocakinogene sifuplasmid 2olaparib 2niraparib 2Transurethral Resection of Bladder 2Surveys and Questionnaires 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2OKN 007 2Mycophenolic Acid 2Metformin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Glioblastoma × Radiation Dose Hypofractionation × Clear all
NCT01985087 2024-10-31

A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70

University of Louisville

Phase 1/2 Active not recruiting
18 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡